STRS OHIO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$150
-56.3%
7,3000.0%0.00%0.0%
Q2 2023$343
-99.8%
7,300
+55.3%
0.00%0.0%
Q3 2022$184,000
-27.8%
4,700
-40.5%
0.00%0.0%
Q2 2022$255,000
-80.5%
7,900
-65.8%
0.00%
-80.0%
Q2 2021$1,311,000
+58.7%
23,093
+109.1%
0.01%
+66.7%
Q1 2021$826,000
-78.0%
11,043
-78.8%
0.00%
-81.2%
Q4 2019$3,753,000
-83.2%
52,000
-67.4%
0.02%
-67.3%
Q3 2019$22,344,000
-0.4%
159,284
+30.0%
0.05%
-51.0%
Q2 2019$22,436,000
-29.3%
122,543
-38.6%
0.10%
-30.6%
Q1 2019$31,730,000
+44.0%
199,500
-13.3%
0.14%
+28.6%
Q4 2018$22,031,000
+9.5%
230,000
+61.5%
0.11%
+27.3%
Q3 2018$20,116,000
+505.9%
142,417
+571.4%
0.09%
+528.6%
Q2 2018$3,320,000
-32.4%
21,211
-30.5%
0.01%
-36.4%
Q1 2018$4,912,000
+4.3%
30,500
+6.6%
0.02%
+10.0%
Q4 2017$4,710,000
+8.2%
28,600
-59.1%
0.02%
+5.3%
Q3 2017$4,354,000
+0.7%
69,900
+28.7%
0.02%0.0%
Q2 2017$4,324,000
-41.3%
54,300
-47.6%
0.02%
-40.6%
Q1 2017$7,362,000
+39.5%
103,600
+0.2%
0.03%
+39.1%
Q4 2016$5,279,000
+17.6%
103,400
+6.1%
0.02%
+15.0%
Q3 2016$4,489,000
+1794.1%
97,500
+1217.6%
0.02%
+1900.0%
Q1 2016$237,000
-68.7%
7,400
-43.1%
0.00%
-66.7%
Q4 2015$757,000
+37.6%
13,0000.0%0.00%0.0%
Q3 2015$550,000
-42.0%
13,0000.0%0.00%
-25.0%
Q2 2015$949,00013,0000.00%
Q1 2015$0
-100.0%
0
-100.0%
0.00%
Q4 2014$73,000
-42.1%
2,000
-50.0%
0.00%
Q3 2014$126,0004,0000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders